Current development of CFTR potentiators in the last decade

Eur J Med Chem. 2020 Oct 15:204:112631. doi: 10.1016/j.ejmech.2020.112631. Epub 2020 Jul 15.

Abstract

Cystic fibrosis (CF) is a genetic disorder produced by the loss of function of CFTR, a main chloride channel involved in transepithelial salt and water transport. CFTR function can be rescued by small molecules called "potentiators" which increase gating activity of CFTR on epithelial surfaces. High throughput screening (HTS) assays allowed the identification of new chemical entities endowed with potentiator properties, further improved through medicinal chemistry optimization. In this review, the most relevant classes of CFTR potentiators developed in the last decade were explored, focusing on structure-activity relationships (SAR) of the different chemical entities, as a useful tool for the improvement of their pharmacological activity.

Keywords: CFTR; CFTR potentiators; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; VX-770.

Publication types

  • Review

MeSH terms

  • Aminophenols / pharmacology
  • Cystic Fibrosis Transmembrane Conductance Regulator / drug effects*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Glycine / pharmacology
  • Humans
  • Mutation
  • Quinolones / pharmacology
  • Small Molecule Libraries / pharmacology*
  • Structure-Activity Relationship
  • Triazoles / pharmacology

Substances

  • Aminophenols
  • Quinolones
  • Small Molecule Libraries
  • Triazoles
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Glycine